Psychedelic and MDMA-assisted therapies show promise for mental health conditions but face safety concerns outside clinical settings. The FDA rejected an MDMA-assisted therapy application, ...

A comprehensive peer-reviewed invited review published today in Psychedelics by Dr. Kenji Hashimoto and colleagues (Dr. Mingming Zhao and Dr. Jianjun Yang) synthesizes the evolving landscape of ...

Untreated mental health concerns remain devastating for our nation, and there is an ongoing need for expanded options and access. In the past few years, there has been a resurgence in interest in ...

MDMA (3,4-methylenedioxymethamphetamine), known colloquially as Molly and Ecstasy, is a synthetic drug with effects similar to stimulants like methamphetamine. It was first synthesized in 1912 by ...

As psychedelic-assisted therapy grows in popularity, several substances are being recognized for their potential in treating trauma. Psilocybin, ketamine, and MDMA have emerged as some of the most ...

WASHINGTON (AP) — Federal health regulators are questioning the safety and evidence behind the first bid to use MDMA, the mind-altering club drug, as a treatment for PTSD, part of a decadeslong effort ...

Only two drugs are formally approved for post-traumatic stress disorder, or PTSD, and they don’t help everyone. A lack of effective treatment options has led some patients to seek out the psychedelic ...

The use of the active ingredient 3,4-methylenedioxy-N-methylamphetamine (MDMA), commonly known as "ecstasy", to support psychotherapy for mental illnesses such as post-traumatic stress disorder is ...